Patient Preferences for Change in Symptoms Associated with Opioid-Induced Constipation

Advances in Therapy

Volumn 31, Issue 12, 2014, Pages 1263-1271

  Epstein, Robert S ^a   Cimen, Ali ^b   Benenson, Hannah ^c   Aubert, Ronald E ^a   Khalid, Mona ^a   Sostek, Mark B ^b   Salimi, Tehseen ^b  

^a Epstein Health   (United States)

^b ASTRAZENECA   (United Kingdom)

^c BROWN UNIVERSITY   (United States)

Author keywords

Burden; Chronic pain; Constipation; Opioid induced constipation; Opioids; Patient; Symptoms

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ABNORMAL FECES; ADULT; ARTICLE; BLOATING; CHRONIC PAIN; CONSTIPATION; FEMALE; HUMAN; INTESTINE MOTILITY; MAJOR CLINICAL STUDY; MALE; PATIENT PREFERENCE; CHEMICALLY INDUCED; CROSS-SECTIONAL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; SYMPTOM ASSESSMENT;

ANALGESICS, OPIOID; CHRONIC PAIN; CONSTIPATION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT PREFERENCE; SURVEYS AND QUESTIONNAIRES; SYMPTOM ASSESSMENT;

EID: 84919875035     PISSN: 0741238X     EISSN: 18658652     Source Type: Journal    
DOI: 10.1007/s12325-014-0169-x     Document Type: Article

References (16)

1. Quigley C. Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev. 2004;3:CD004847.
2. Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg. 2001;182(5A Suppl.):11S–8S.
3. Bell TJ, Panchal SJ, Miaskowski C, Bolge SC, Milanova T, Williamson R. The prevalence, severity and impact of opioid-induced bowel dysfunction: results of a US and European patient survey (PROBE 1). Pain Med. 2009;10:35–42.
4. Panchal SJ, Müller-Schwefe P, Wurzelmann JI. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract. 2007;61:1181–7.
5. Brown RT, Zuelsdorff M, Fleming M. Adverse effects and cognitive function among primary care patients taking opioids for chronic nonmalignant pain. J Opioid Manag. 2006;2:137–46.
6. Cook SF, Lanza L, Zhou X, et al. Gastrointestinal side effects in chronic opioid users: results from a population-based survey. Aliment Pharmacol Ther. 2008;27:1224–32.
7. Allan L, Jensen H, Hays NH, et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ. 2001;322:1154–8.
8. Dorn S, Lembo A, Cremonini F. Opioid-induced bowel dysfunction: epidemiology, pathophysiology, diagnosis, and initial therapeutic approach. Am J Gastroenterol. 2014;2:31–7.
9. Cherny N, Ripamonti C, Pereira J, et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol. 2001;19:2542–54.
10. Coyne KS, LoCasale RJ, Datto CJ, Sexton CC, Yeomans K, Tack J. Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart review. Clinicoecon Outcomes Res. 2014;6:269–81.
11. Dinghra L, Shuk E, Grossman B, et al. A qualitative study to explore psychological distress and illness burden associated with opioid-induced constipation in cancer patients with advanced disease. Palliat Med. 2013;27:447–56.
12. Camilleri M, Drossman DA. Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid induced constipation. Neurogastroenterol Motil. 2014;10:1386–95.
13. Penning-van-Beest FJ, van den Haak P, Klok RM, Prevoo YF, van der Peet DL, Herings RM. Quality of life in relation to constipation among opioid users. J Med Econ. 2010;13:129–35.
14. Leslie J, Bell T, Annunziata K, Freedman D. Opioid-induced constipation compromises pain management and impacts patient quality of life. Anesthesiology. 2006;105:Abstr 1490.
15. Nederhof AJ. Methods of coping with social desirability bias: a review. Eur J Soc Psychol. 1985;15:263–80.
16. Zajacova A, Dowd JB. Reliability of self-related health in US adults. Am J Epidemiol. 2011;174:977–83.